Smith & Nephew plc Given Hold Rating at Berenberg Bank (SN)
Smith & Nephew plc (LON:SN)‘s stock had its “hold” rating reiterated by research analysts at Berenberg Bank in a report released on Tuesday. They currently have a GBX 920 ($15.22) price target on the stock. Berenberg Bank’s price objective would suggest a potential downside of 13.04% from the company’s current price.
A number of other firms have also recently commented on SN. Analysts at Morgan Stanley downgraded shares of Smith & Nephew plc to an “equal weight” rating in a research note on Friday, August 15th. They now have a GBX 1,026 ($16.98) price target on the stock, up previously from GBX 980 ($16.22). Separately, analysts at Societe Generale reiterated a “sell” rating on shares of Smith & Nephew plc in a research note on Tuesday, August 5th. They now have a GBX 700 ($11.58) price target on the stock. Finally, analysts at Deutsche Bank reiterated a “buy” rating on shares of Smith & Nephew plc in a research note on Monday, August 4th. They now have a GBX 1,225 ($20.27) price target on the stock. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and six have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of GBX 983.29 ($16.27).
Smith & Nephew plc (LON:SN) traded down 0.66% on Tuesday, hitting GBX 1051.00. 1,313,807 shares of the company’s stock traded hands. Smith & Nephew plc has a one year low of GBX 737.50 and a one year high of GBX 1136.00. The stock has a 50-day moving average of GBX 1035.06 and a 200-day moving average of GBX 975.5. The company’s market cap is £9.396 billion.
Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (LON:SN) and advanced wound management.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with Analyst Ratings Network's FREE daily email newsletter.